NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

NCT07361354

CompletedPhase 1

Sponsor: Angitia Incorporated Limited

Conditions: Healthy Participants, Pharmacokinetic Study

Interventions: AGA2118

Countries: United States

This study will evaluate the effects of a single dose of AGA2118 in Japanese, Chinese, and Caucasian participants

Eligibility overview

Sex: ALL

Age: 18 Years to 65 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Healthy males or females, aged 18 to 65 years
* 25-hydroxyvitamin D ≥30 ng/mL and agree to taking calcium and vitamin D supplements during the study
* Meet the criteria for Japanese, Chinese, or Caucasian ethnicity

Exclusion Criteria:

* Participating or have participated in another clinical trial within the past 6 months
* Any bone fracture within the past 6 months
* History of myocardial infarction or stroke within the past 12 months
* Malignancy within the past 5 years
* Current hyper- or hypocalcemia
* Pregnant or breastfeeding women, or women planning to become pregnant during the study

Locations (1)

Glendale, California, United States